Molecular characterization of apoptosis by the immunohistochemical evaluation of Bcl-2 in breast cancer.

Abstract

Assessment of apoptosis by Bcl-2 leads to the identification of molecular groups with different immunohistochemical and clinical features and different survival rates, better for Bcl-2 positive tumors and worse in Bcl-2 negative tumors.